Public Meetings to Discuss the FSMA Proposed Rule for Requirements for Additional Traceability Records for Certain Foods
December 2, 2020
- December 2, 2020
The U.S. Food and Drug Administration (FDA) held a series of three virtual one-day public meetings to discuss the recently released proposed rule “Requirements for Additional Traceability Records for Certain Foods.” The purpose of the public meetings was to discuss the proposed rule, which was issued under the FDA Food Safety Modernization Act, and to support the public's evaluation and commenting process on the proposed rule.
The public meetings were held according to the schedule below. Materials associated with each meeting are also included below.
For additional information, see the Federal Register Notice announcing the meetings.
Presented by Andrew Kennedy, New Era Technology Team Leader, FDA Office of Food Policy and Response
During each of the three public meetings to discuss the Proposed Rule, “Requirements for Additional Traceability Records for Certain Foods” (Food Traceability Proposed Rule) Andrew Kennedy from the FDA’s Office of Food Policy and Response walked through a supply chain example of a salad kit prepared with cherry tomatoes, iceberg lettuce, and other foods, with a focus on the tomato grower, salad kit maker, distributor, and retail store. As discussed at the public meetings, this is only one example and it does NOT represent the only way data could be kept and shared under the proposed requirements.
Linked below are the slides from that presentation, a video of that presentation, and a PDF containing a more detailed overview of the example in the presentation. None of the posted materials make changes to the proposed rule. We are providing these resources to help increase stakeholder awareness and understanding of the proposal. FDA will carefully consider comments submitted to the public docket when drafting the final rule, which may differ from the proposed rule. Interested parties are encouraged to submit comments during the comment period, which has been extended until February 22, 2021. Comments can be submitted to regulations.gov, Docket ID: FDA-2014-N-0053.